Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningGranulocyte Colony-Stimulating FactorTransplantation, HomologousMelphalanLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalCyclophosphamideStem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationEtoposideHematopoietic Stem CellsThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisCytarabineHematopoiesisStem CellsHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsRetrospective StudiesSurvival RateTissue DonorsWhole-Body IrradiationDoxorubicinSurvival AnalysisTime FactorsInfectionLymphoma, T-CellRecombinant ProteinsPlatelet CountHistocompatibilityPOEMS SyndromeCarboplatinPrednisoneHistocompatibility TestingImmunosuppressive AgentsBlood Cell CountLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineFollow-Up StudiesLeukemiaAntineoplastic AgentsLymphomaBone Marrow PurgingProspective StudiesCytomegalovirus InfectionsBlood CellsGraft vs Leukemia EffectFeasibility StudiesFatal OutcomeMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticBlood Transfusion, AutologousLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesLymphocyte DepletionLeukocytes, MononuclearT-LymphocytesBreast NeoplasmsHistiocytosis, Non-Langerhans-CellNeutropeniaLivedo ReticularisOpportunistic InfectionsBlood DonorsFeverPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisBone MarrowHLA AntigensCyclosporineLeukocyte Count